Prevalenţa sindromului cardiorenal 2/4 la pacienţii cu insuficienţă cardiacă cu fracţie de ejecţie redusă sau moderat redusă

Bivol Elena; Grib Liviu; Sasu Boris

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

889

Ultima descărcare din IBN:
2023-11-25 11:00

Căutarea după subiecte
similare conform CZU

616.12-008.46-06:616.61 (5)

Патология сердечно-сосудистой системы. Сердечно-сосудистые заболевания (996)

Заболевания опорно-двигательной системы. Скелет и мышечная система (401)

SM ISO690:2012

BIVOL, Elena, GRIB, Liviu, SASU, Boris. Prevalenţa sindromului cardiorenal 2/4 la pacienţii cu insuficienţă cardiacă cu fracţie de ejecţie redusă sau moderat redusă. In: Sănătate Publică, Economie şi Management în Medicină , 2017, nr. 3(73), pp. 67-69. ISSN 1729-8687.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Sănătate Publică, Economie şi Management în Medicină

Numărul 3(73) / 2017 / ISSN 1729-8687 /ISSNe 2587-3873

Prevalenţa sindromului cardiorenal 2/4 la pacienţii cu insuficienţă cardiacă cu fracţie de ejecţie redusă sau moderat redusă

The prevalence of cardiac 2/4 syndrome in patients with reduced and moderately low ejection fraction

CZU: 616.12-008.46-06:616.61

Pag. 67-69

Bivol Elena¹², Grib Liviu¹, Sasu Boris²¹

¹ Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“,
² Spitalul Clinic Municipal „Sfânta Treime”

Disponibil în IBN: 31 octombrie 2017

Descarcă PDF

Rezumat

Prevalence of cardiorenal diseases is increasing and is accompanied by high mortality and morbidity. The aim of this study was to estimate the prevalence of type 2/4 cardiorenal syndrome in heart failure patients with reduced ejection fraction. The retrospective study included 194 heart failure patients with reduced and moderate-reduced ejection fraction hospitalized in January 2014 – December 2015 in the Department of Cardiology, CH “Sfanta Treime”. 194 patients were evaluated: 113 subjects with moderate-reduced ejection fraction (EF) 40-49%; and 81 subjects with reduced EF <40%. Patients with moderate-reduced EF were 67.89 y.o., 49.6% were men. The estimative glomerular fi ltration rate (GFRe) was 73.15 mL/min/1.73 m2, GFRe ≤ 60 mL/ min/1.73 m2 was recorded in 30.9%. The proteinuria prevalence was 62.8% and 78.57% in those with GFRe ≤ 60 mL/ min/1.73 m2. Patients with reduced EF had mean age 64.69 years, 74.07% men. GFRe was 76.37 mL/min/1.73 m2, GFRe ≤ 60 mL/min/1.73 m2 was recorded in 28.39% cases. The proteinuria prevalence was 77.8% in the sample, and 100% in those with GFRe ≤ 60 mL/min/1.73 m2. The results confi rm that the prevalence of renal impairment in heart failure is high, whether we focus on GFR or proteinuria.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-55512</cfResPublId>
<cfResPublDate>2017-07-01</cfResPublDate>
<cfVol>73</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>67</cfStartPage>
<cfISSN>1729-8687</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/55512</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Prevalenţa sindromului cardiorenal 2/4 la pacienţii cu insuficienţă cardiacă cu fracţie de ejecţie redusă sau moderat redusă</cfTitle>
<cfAbstr cfLangCode='EN' cfTrans='o'><p><em>Prevalence of cardiorenal diseases is increasing and is accompanied by high mortality and morbidity. The aim of this study was to estimate the prevalence of type 2/4 cardiorenal syndrome in heart failure patients with reduced ejection fraction. The retrospective study included 194 heart failure patients with reduced and moderate-reduced ejection fraction hospitalized in January 2014 &ndash; December 2015 in the Department of Cardiology, CH &ldquo;Sfanta Treime&rdquo;. 194 patients were evaluated: 113 subjects with moderate-reduced ejection fraction (EF) 40-49%; and 81 subjects with reduced EF &lt;40%. Patients with moderate-reduced EF were 67.89 y.o., 49.6% were men. The estimative glomerular fi ltration rate (GFRe) was 73.15 mL/min/1.73 m</em><em>2</em><em>, GFRe &le; 60 mL/ min/1.73 m</em><em>2 </em><em>was recorded in 30.9%. The proteinuria prevalence was 62.8% and 78.57% in those with GFRe &le; 60 mL/ min/1.73 m</em><em>2</em><em>. Patients with reduced EF had mean age 64.69 years, 74.07% men. GFRe was 76.37 mL/min/1.73 m</em><em>2</em><em>, GFRe &le; 60 mL/min/1.73 m</em><em>2 </em><em>was recorded in 28.39% cases. The proteinuria prevalence was 77.8% in the sample, and 100% in those with GFRe &le; 60 mL/min/1.73 m</em><em>2</em><em>. The results confi rm that the prevalence of renal impairment in heart failure is high, whether we focus on GFR or proteinuria.</em></p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-18608</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-11112</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12028</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-18608</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-18608-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Bivol</cfFamilyNames>
<cfFirstNames>Elena</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-11112</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11112-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Grib</cfFamilyNames>
<cfFirstNames>Liviu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12028</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12028-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2017-07-01T24:00:00</cfStartDate>
<cfFamilyNames>Sasu</cfFamilyNames>
<cfFirstNames>Boris</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>